Gastroenterology Expansion And Global Markets Will Unlock Opportunities
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
11 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$7.08
13.2% overvalued intrinsic discount15 Aug
US$8.02
1Y
39.5%7D
20.4%